Fibroblast growth factor 20 attenuates pathological cardiac hypertrophy by activating the SIRT1 signaling pathway

Cardiac hypertrophy occurs initially in response to an increased cardiac load as a compensatory mechanism to maintain cardiac output. However, sustained pathological hypertrophy can develop into heart failure and cause sudden death. Fibroblast growth factor 20 (FGF20) is a member of the fibroblast g...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yunjie, An, Ning, Zhou, Xuan, Mei, Lin, Sui, Yanru, Chen, Gen, Chen, Huinan, He, Shengqu, Jin, Cheng, Hu, Zhicheng, Li, Wanqian, Wang, Yang, Lin, Zhu, Chen, Peng, Jin, Litai, Guan, Xueqiang, Wang, Xu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964679/
https://www.ncbi.nlm.nih.gov/pubmed/35351862
http://dx.doi.org/10.1038/s41419-022-04724-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964679/
https://www.ncbi.nlm.nih.gov/pubmed/35351862
http://dx.doi.org/10.1038/s41419-022-04724-w

Ejemplares similares